Kaplan Fox Reminds Cellebrite DI Ltd. (NASDAQ: CLBT) Investors of an Ongoing Securities Law InvestigationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBTNEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (
NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Kaplan Fox Urges Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to Contact the Firm Regarding a Securities InvestigationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) on Behalf of InvestorsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBTNEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (
NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Kaplan Fox Advises Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) of an Investigation Into Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Notifies Cellebrite DI Ltd. (NASDAQ: CLBT) Investors of an Investigation Into Possible Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to an Ongoing Investigation Into Possible Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBTNEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (
NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Kaplan Fox Encourages Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to Contact the Firm Regarding an Ongoing Securities InvestigationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Possible Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS LawSchall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cellebrite DI Ltd. (“Cellebrite” or “the Company”) (
NASDAQ: CLBT) for violations of the securities laws.
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Possible Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox is Investigating Possible Securities Law Violations Against Cellebrite DI Ltd. (NASDAQ: CLBT)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Contact the Firm Regarding Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Reminds Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) of an Ongoing Investigation Into Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Announces an Investigation of Cellebrite DI Ltd. (NASDAQ: CLBT) on Behalf of InvestorsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox is Investigating Potential Securities Law Violations Against Cellebrite DI Ltd. (NASDAQ: CLBT)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Notifies Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) of an Investigation Into Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
CLBT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Cellebrite DI Ltd. (CLBT)
Shareholders of Cellebrite DI Ltd. (CLBT) took losses when the stock sold off following Q2 2026 revenue of approximately $131.1 million and a reduction in the Company's full-year 2026 ARR and revenue guidance. If you held CLBT shares and lost money, you have rights and a limited window to assert them -- click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation PlatformThe addition of Corellium’s leading virtualization technology to the Cellebrite platform delivers unmatched capabilities that transcend digital forensics, investigations, analytics and intelligence
Cellebrite Announces Third-Quarter 2025 ResultsARR grew 19% to $439.8 million; Revenue grew 18% to $126.0 million
